As part of a BBC Horizons program on medical innovations, Penn Dental’s Dr. Henry Daniell shares his plant-based platform for producing vaccines and biopharmaceuticals.
The National Cancer Institute spotlights the research of grantee Dr. Akintoye, who is studying the behavior of jaw bone stem cells and cancer treatment complications.
Featured in the May/June issue of The Pennsylvania Gazette, is a story on the research of Dr. Henry Daniell, Professor, Depts. of Biochemistry and Pathology.
Dr. Daniell has developed a new technology that relies on plant cells to produce and deliver human therapeutic protiens to treat infectious and inherited diseases.
Dr. Henry Daniell discusses his novel platform for producing and delivering drugs through plants on NPR’s The Pulse with Maiken Scott.
